Achieve Life Sciences, Inc. (ACHV) vs Collegium Pharmaceutical, Inc. (COLL)

A side-by-side comparison of Achieve Life Sciences, Inc. and Collegium Pharmaceutical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ACHV vs COLL

growth of $100 · dividends reinvested · last 10y
ACHV -99.3% (-38.9%/yr)COLL +14.8% (+1.4%/yr)COLL compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020182020202220242026$1$115
ACHV COLL

ACHV vs COLL: by the numbers

  • •ACHV is the larger company ($720M vs $709M market cap).
  • •COLL is profitable (5.93% net margin) while ACHV runs a net loss (0.00%).

Metrics side by side

Valuation

MetricACHVCOLL
P/E ratioN/A17.64
PEG ratioN/A0.99
P/S ratioN/A0.88
P/B ratioN/A2.27
EV / EBITDAN/A2.84
FCF yieldN/A46.28%

Profitability

MetricACHVCOLL
Gross margin0.00%60.02%
Operating margin0.00%19.61%
Net margin0.00%5.93%
ROEN/A15.36%
ROICN/A6.11%

Growth (annualized)

MetricACHVCOLL
Revenue CAGR (5Y)N/A19.91%
EPS CAGR (5Y)N/A20.48%
FCF CAGR (5Y)N/A26.38%
Total return CAGR (5Y)-4.33%2.15%

Frequently asked

Is ACHV or COLL more profitable?
COLL runs the higher net margin — ACHV at 0.00% versus COLL at 5.93%.
How have ACHV and COLL total returns compared?
Over the past 10 years, ACHV delivered -39.18% and COLL delivered 1.39% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.